Intelligence Platform
Patents
Browse 19 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11648287
Composition for the treatment of intracellular bacterial infection
granted patentUS 11534465
Fecal matter for treatment of autoimmune diseases
granted patentUS 11344618
HIV envelope glycoprotein immunogens
granted patentUS 11103504
Combination of a DNA condensation-inducing compound and an Eis inhibitor for antibiotic tr
granted patentUS 10974041
Neuromodulation device
granted patentUS 10590082
N-(5-((aryl or heteroaryl)methyloxy)pentyl)-substituted iminosugars as inhibitors of gluco
granted patentUS 10456439
NK3 agonist for use in the treatment of a patient suffering from atrial arrhythmia or fibr
granted patentUS 10280218
Antibodies binding to BMP4, and uses thereof
granted patentUS 10189784
N-(5-((aryl or heteroaryl)methyloxy)pentyl)-substituted iminosugars as inhibitors of gluco
granted patentUS 10130677
Antimicrobial peptide and uses thereof
granted patentUS 9623055
Method for preventing and/or treating insulin resistance
granted patentUS 9433650
Method for preventing and/or treating insulin resistance
granted patentUS 9056847
Activity based probes (ABPs) interacting with glycosidases
granted patentUS 8981057
B-cell stimulating fusion proteins of an antigen with BAFF or APRIL
granted patentUS 8529885
AAV vectors for in vivo gene therapy of rheumatoid arthritis
granted patentUS 8524194
Radiolabelled MMP selective compounds
granted patentUS 8410081
Treatment of cystic fibrosis
granted patentUS 8008038
Methods for determining oxygen concentration with protoporphyrin IX
granted patentUS 6624140
Synthetic peptides with antimicrobial and endotoxin neutralizing properties for management
expired